Skip to main content
EVRYSDI 5 mg/1 tablet by Genentech, Inc.
EVRYSDI, 5 mg/1, tablet Drug class: Survival of Motor Neuron 2 Splicing Modifier. Available on prescription only. Listed by Genentech, Inc..
Prescription only

EVRYSDI

Risdiplam

Listed by Genentech, Inc.

Strength
5 mg/1
Form
Tablet
Route
Oral
Class
Survival of Motor Neuron 2 Splicing Modifier

What it contains

  • Risdiplam 5 mg/1

FDA record

Dosage form Tablet
Route Oral
Drug class Survival of Motor Neuron 2 Splicing Modifier
Approval route NDA — original brand approval
NDC code 50242-202
FDA application NDA219285
RxNorm concept 2390940
Package sizes listed 1
Marketed since February 2025

Other products containing Risdiplam

See all

Same active ingredient, different manufacturer, strength or form. Products matching on both ingredient and strength are usually interchangeable — but confirm before switching, especially with modified-release forms.

EVRYSDI

Risdiplam

Strength
.75 mg/mL
Form
Powder, For Solution
Class
Survival of Motor Neuron 2 Splicing Mod…
Rx only

Genentech, Inc.

Not stocked by us — reference only

Information only, not medical advice. Nothing on this page indicates that a medication is safe or suitable for you. Speak to a prescriber or pharmacist before starting, stopping or switching any medicine.